When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Susan Blackborough was just 12 when she was diagnosed with multiple sclerosis and was told she would lose her ability to walk ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

A man from the Dallas area isn't letting his Multiple Sclerosis diagnosis keep him down as he hopes to climb Mount Scott.

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

The nonprofit nominated for June’s 3-Degree Guarantee was the Multiple Sclerosis Alliance of Southern Colorado (MSA). This ...

Multiple Sclerosis MS is an autoimmune condition that can remain undetected for years A doctor explains how long MS can stay ...

A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.

The multiple sclerosis (MS) disease-modifying therapy (DMT) market across the seven major markets (7MM: the US, France, ...

It’s one of the most talked-about nutrients of 2025, and also one of the most divisive. Many prominent nutrition influencers ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...